Filing Details
- Accession Number:
- 0000950170-23-067072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-30 17:00:07
- Reporting Period:
- 2023-11-30
- Accepted Time:
- 2023-11-30 17:00:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1833214 | Sab Biotherapeutics Inc. | SABS | Biological Products, (No Disgnostic Substances) (2836) | 853899721 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1998530 | Michael King | 2100 E 54Th Street North Sioux Falls SD 57104 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-30 | 5,000 | $0.90 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents 5,000 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.
Billionaire Hedge Funds
